In RA patients that do not respond to anti-TNF therapy, these CTLs display a TEMRA phenotype and are able to kill Tregs in vitro after stimulation with apoptotic epitopes, via a NKG2D-dependent mechanism. Here, TNF is linked to rheumatoid arthritis.